Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Aug 15;295(6595):421–424. doi: 10.1136/bmj.295.6595.421

Human immunodeficiency virus and drug misuse: the Edinburgh experience.

R P Brettle 1, K Bisset 1, S Burns 1, J Davidson 1, S J Davidson 1, J M Gray 1, J M Inglis 1, J S Lees 1, J Mok 1
PMCID: PMC1247280  PMID: 3115484

Abstract

During 1985 many drug abusers who lived in Edinburgh were found to be infected with the human immunodeficiency virus (HIV). As a result an alternative counselling and screening clinic for testing for antibodies to HIV was established for use by drug abusers. Four hundred and forty one patients were counselled in the first year, and over 60% were either drug abusers or their sexual contacts. One hundred and fourteen (26%) patients were positive for HIV antibody, and 100 (88%) of these were current or former drug abusers. The HIV seropositivity rate in drug abusers was 52% but was only 7% in their sexual contacts. Services were provided for these people as well as counselling before and after the test. The cost of this counselling service for the first year was 27,000 pounds or 61.22 pounds per patient. The unexpected mobility of 23% of the Edinburgh drug abusers, particularly to other areas of Britain, suggests that similar services need to be set up elsewhere.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brettle R. P., Davidson J., Davidson S. J., Gray J. M., Inglis J. M., Conn J. S., Bath G. E., Gillon J., McClelland D. B. HTLV-III antibodies in an Edinburgh clinic. Lancet. 1986 May 10;1(8489):1099–1099. doi: 10.1016/s0140-6736(86)91367-x. [DOI] [PubMed] [Google Scholar]
  2. Brettle R. P. Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med J (Clin Res Ed) 1986 Jun 21;292(6536):1671–1671. doi: 10.1136/bmj.292.6536.1671-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Follett E. A., McIntyre A., O'Donnell B., Clements G. B., Desselberger U. HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet. 1986 Feb 22;1(8478):446–447. doi: 10.1016/s0140-6736(86)92405-0. [DOI] [PubMed] [Google Scholar]
  4. Franceschi S., Tirelli U., Vaccher E., Serraino D., Sorio R., Carbone A., Monfardini S. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base. Lancet. 1986 Apr 5;1(8484):804–804. doi: 10.1016/s0140-6736(86)91815-5. [DOI] [PubMed] [Google Scholar]
  5. Jesson W. J., Thorp R. W., Mortimer P. P., Oates J. K. Prevalence of anti-HTLV-III in UK risk groups 1984/85. Lancet. 1986 Jan 18;1(8473):155–155. doi: 10.1016/s0140-6736(86)92288-9. [DOI] [PubMed] [Google Scholar]
  6. Levy N., Carlson J. R., Hinrichs S., Lerche N., Schenker M., Gardner M. B. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med. 1986 Feb 13;314(7):446–446. doi: 10.1056/NEJM198602133140711. [DOI] [PubMed] [Google Scholar]
  7. Peutherer J. F., Edmond E., Simmonds P., Dickson J. D., Bath G. E. HTLV-III antibody in Edinburgh drug addicts. Lancet. 1985 Nov 16;2(8464):1129–1130. doi: 10.1016/s0140-6736(85)90721-4. [DOI] [PubMed] [Google Scholar]
  8. Robertson J. R., Bucknall A. B., Welsby P. D., Roberts J. J., Inglis J. M., Peutherer J. F., Brettle R. P. Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):527–529. doi: 10.1136/bmj.292.6519.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Robertson J. R., Bucknall A. B., Wiggins P. Regional variations in HIV antibody seropositivity in British intravenous drug users. Lancet. 1986 Jun 21;1(8495):1435–1436. doi: 10.1016/s0140-6736(86)91571-0. [DOI] [PubMed] [Google Scholar]
  10. Scott G. B., Fischl M. A., Klimas N., Fletcher M. A., Dickinson G. M., Levine R. S., Parks W. P. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA. 1985 Jan 18;253(3):363–366. [PubMed] [Google Scholar]
  11. Spira T. J., Des Jarlais D. C., Marmor M., Yancovitz S., Friedman S., Garber J., Cohen H., Cabradilla C., Kalyanaraman V. C. Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med. 1984 Aug 16;311(7):467–468. doi: 10.1056/NEJM198408163110712. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES